Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sorin outlines strategy to boost profitability

This article was originally published in Clinica

Executive Summary

A broad strategy to improve profitability drawn up by Sorin's new CEO, Drago Cerchiari, has been approved by the Italian cardiovascular device group's board of directors. The aim is to almost double EBITDA (earnings before interest, tax, depreciation and amortisation) to 20% of revenues by 2008. In 2003 EBITDA declined to 11.4%, or Euros81.5m ($103m), from 14.7% in 2002.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT057410

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel